|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$21,926,350 |
|
|
Indirect Value
|
$61,758 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$21,988,108 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-25 |
4 |
AS |
$211.39 |
$775,989 |
D/D |
(3,634) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-05 |
4 |
OE |
$77.31 |
$792,413 |
D/D |
8,500 |
50,452 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-24 |
4 |
OE |
$86.52 |
$795,522 |
D/D |
8,969 |
50,921 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-02-04 |
4 |
OE |
$86.52 |
$795,657 |
D/D |
7,959 |
54,711 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-07-07 |
4 |
AS |
$300.00 |
$835,800 |
D/D |
(2,786) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-07-13 |
4 |
OE |
$131.89 |
$840,799 |
D/D |
6,375 |
53,127 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-25 |
4 |
AS |
$229.78 |
$849,418 |
D/D |
(3,634) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-03 |
4 |
AS |
$228.90 |
$857,465 |
D/D |
(3,710) |
33,240 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-01-31 |
4 |
OE |
$187.53 |
$879,891 |
D/D |
4,692 |
37,932 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-27 |
4 |
AS |
$141.41 |
$905,598 |
D/D |
(6,290) |
116,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2013-10-01 |
4 |
AS |
$75.73 |
$947,166 |
D/D |
(12,417) |
39,334 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-02-17 |
4 |
D |
$232.51 |
$959,336 |
D/D |
(4,126) |
72,312 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-10 |
4 |
D |
$294.33 |
$992,481 |
D/D |
(3,372) |
92,880 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-05 |
4 |
AS |
$172.08 |
$998,580 |
D/D |
(5,803) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-03 |
4 |
AS |
$174.20 |
$1,010,883 |
D/D |
(5,803) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-04-15 |
4 |
AS |
$180.95 |
$1,022,148 |
D/D |
(5,624) |
33,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-08-15 |
4 |
OE |
$155.57 |
$1,022,250 |
D/D |
6,571 |
67,451 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-12 |
4 |
AS |
$150.78 |
$1,042,833 |
D/D |
(6,824) |
55,701 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-11 |
4 |
AS |
$210.39 |
$1,085,593 |
D/D |
(5,156) |
61,700 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-01-31 |
4 |
AS |
$238.65 |
$1,119,746 |
D/D |
(4,692) |
33,240 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-09-04 |
4 |
AS |
$124.43 |
$1,139,818 |
D/D |
(9,063) |
127,515 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-07-13 |
4 |
AS |
$179.00 |
$1,141,125 |
D/D |
(6,375) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-08-05 |
4 |
OE |
$45.11 |
$1,168,141 |
D/D |
19,828 |
147,343 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-04-28 |
4 |
OE |
$45.11 |
$1,277,515 |
D/D |
28,320 |
159,567 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-10-30 |
4 |
AS |
$123.36 |
$1,298,794 |
D/D |
(10,350) |
104,748 |
0 |
- |
|
192 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|